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ABSTRACT 
 
 
 The goal of this study is to better simulate microscopic and voxel-based dynamic 
contrast enhancement in magnetic resonance imaging.  Specifically, errors imposed by 
the traditional two-compartment model are reduced by introducing a novel Krogh 
cylinder network.  The two-compartment model was developed for macroscopic 
pharmacokinetic analysis of dynamic contrast enhancement and generalizing it to voxel 
dimensions, due to the significant decrease in scale, imposes physiologically unrealistic 
assumptions. In the project, a system of microscopic exchange between plasma and 
extravascular-extracellular space is built while numerically simulating the local contrast 
agent flow between and inside image elements.  To do this, tissue parameter maps 
were created, contrast agent was introduced to the tissue via a flow lattice, and various 
data sets were simulated.  The effects of sources, tissue heterogeneity, and 
the contribution of individual tissue parameters to an image are modeled.  Further, the 
study attempts to demonstrate the effects of a priori flow maps on image contrast, 
indicating that flow data is as important as permeability data when analyzing tumor 
contrast enhancement.  In addition, the simulations indicate that it may be possible to 
obtain tumor-type diagnostic information by acquiring both flow and permeability data.
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CHAPTER 1 
 
BACKGROUND 
 
1.1 Pharmacokinetic Introduction 
 
 Motion of particles within the human body has been studied throughout the history of 
medical imaging.  Modern molecules of interest include oxygen and contrast agents as they 
move through the blood.  Many models exist that describe exchange of molecules between blood 
and tissue on the order of microns within an individual capillary.  Similarly, there are larger scale 
models that describe the behavior of injected molecules as they exchange on an image pixel 
basis, such as Gadolinium (Gd) used as a contrast agent in magnetic resonance imaging (MRI).  
These two realms of agent transport, however, have a large disconnect of scale that is, as yet, 
poorly addressed.   
 In the application of contrast agents to cancer, a physician frequently seeks to take 
advantage of a particular parameter or set of parameters that allow differentiation of healthy and 
diseased tissue.  For example, some forms of cancer exhibit increased vascular permeability and 
consequently demonstrate a rapid uptake of contrast agent as compared to healthy tissue 
(Kershaw and Buckley 986-992).  From a larger intensity in one region of the MRI image, a 
clinician may have an indication of malignant tissue.  The dynamics of contrast agent movement, 
however, rapidly complicate the application of any imaging results to definitive diagnosis due to 
the host of factors that contribute.  These include but are not limited to chemical interactions 
between the contrast agent and water, location of sources and sinks within the image slice, 
heterogeneous location of diseased tissue within the pixel map, and assumptions of flow. 
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 In the novel Krogh-Lattice (KL) model, the parameters of a slice of tissue are assumed 
and the resulting imaging signal is studied via simulation.  This allows examination of the effects 
of a local change in tissue parameters, such as the addition of an arterial source or a necrotic 
region below the resolution of a pixel, on the greater slice and overall image dynamic.  
Generally, the Krogh-Lattice model seeks to extrapolate a microscopic, capillary-flow based 
mathematical model of contrast agent distribution to a networked set of capillaries on an 
intermediate scale. From this intermediate field of view, the model can be further expanded to 
the scale of a MRI image pixel.   
 
1.2 Compartmental Models 
 
 There are two main approaches to mathematically defining the capillary-tissue exchange 
process for contrast agents.  The first, known as the Conventional Compartmental (CC) model, 
delineates enclosed regions where contrast agent can reside.  Imposing a two compartment limit 
to the CC model, also known as the Two Compartment Model (TCM), these regions represent 
either the plasma in the capillary or the extracellular-extravascular space (EES).  The EES is the 
void space where contrast agent collects between cells that are external to any vasculature.  
Represented mathematically, the concentration of contrast agent in the EES is (	) and in the 
capillary plasma is (	).  Transport of contrast agent is accounted for by volumetric flow rates 
between plasma compartments, known as , and a diffusive process between plasma and the 
EES.  This diffusion can be represented by a directional transfer coefficient such as , for 
contrast agent moving from the capillary to the EES, or by a directional transfer coefficient for 
contrast movement in the opposite direction, .  The source of contrast agent is a function of 
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time and named the arterial input function, (	).  To account for osmotic pressure as contrast 
agent gradients occur, the fractional volumes available to store contrast agent in plasma, , and 
in the EES, , are designated.  Combining these concepts, the mathematical relationship 
governing the CC process is given by equations 1.1 – 1.4 (Murase 858-862).   
 

()

=  − (	) −  (	) +   (	) +  (	)   (1.1) 

()

=   (	) −  (	)    (1.2) 
      (0) =  0                       (1.3) 
(0) = 0             (1.4) 
 
 As observed in equation 1.1, contrast agent concentration in the capillary will increase 
due to the source term of the arterial input function as well as any diffusion from the EES into 
the capillary.  Likewise, contrast agent concentration in the capillary will decrease based upon 
diffusion into the EES and blood flow transporting it away from the local region.  For equation 
1.2, the only methods to change the contrast agent concentration in the EES is from diffusion 
into or out of the capillary.   
 Under the assumption that the directional transfer coefficients,  and , only differ 
slightly based on the associated volume fraction, the permeability surface area product (PS) may 
be defined by equation 1.5 (Koh, “Tracer Kinetics”).   
 
 =   =              (1.5) 
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  If the CC equations 1.1 – 1.4 are rewritten from the PS perspective (instead of K12 or 
K21), then the CC model can be described by equations 1.6 – 1.9 (Koh, “Tracer Kinetics”). 
 

()

=  − (	) −  [(	) −  (	)] +  (	)  (1.6) 

()

=   [(	) −  (	)]    (1.7) 
      (0) =  0                       (1.8) 
(0) = 0             (1.9) 
 
 The key assumption to the CC model is that contrast agent instantaneously distributes 
itself within each compartment such that there are no spatial contrast agent gradients (Cheong, 
Lim and Koh 921-930).  This assumption must be called into question, however, if this model is 
used to represent physiological processes on the microscopic scale of an image pixel or voxel.    
 Conversely, the Distributed Parameter (DP) approach allows for spatial gradients to occur 
as contrast agent is exchanged along the length, L, of a capillary.  Specifically, contrast agent 
concentration within both the capillary and EES now are functions of space and time.  Transport 
of contrast agent remains similar to the CC model.  A general form of the DP model as coupled 
differential equations and boundary conditions is given as equations 1.10 – 1.14 (Koh, “Tracer 
Kinetics”).   
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
"(#,)
"
=  −%   
"(#,)
"#
 – [(', 	) −  (', 	)]   (1.10) 

"(#,)
"
=  ((', 	) −  (', 	))    (1.11) 
      (0, 	) =  (	)     (1.12) 
       (' > 0,0) =  0       (1.13) 
     (0) = 0             (1.14) 
 
 The consequence of this complication, however, is a set of equations that cannot be 
closed (St. Lawrence and Lee 1365-1377).  Figures 1.1 and 1.2 provide a visual comparison of 
the differences between CC and DP models. 
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Figure 1.1 Two Compartment Model 
 
 
Figure 1.2 Distributed Parameter Model 
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1.3 Krogh Cylinder and Tissue Homogeneity 
 
 In order to better represent the geometry of the body, a capillary-tissue exchange model 
can be formed into a pair of concentric cylinders.  Explicitly, the inner cylinder represents the 
capillary and the outer forms the EES.  This method of describing a capillary-tissue pair was first 
proposed by Nobel laureate August Krogh in 1919 in the description of oxygen transport to 
muscle tissue during exercise (McLeod 817-835).   Applying DP concepts and associated 
equations 1.10 – 1.14 to Krogh cylinder geometry, the tissue homogeneity (TH) model is formed 
(Bae 809-816).  In the search to find an analytical solution to the TH model with DP properties, 
the researchers Johnson and Wilson proposed a key assumption in 1966.  Specifically, they 
assumed the contrast agent concentration in the EES is well mixed at all times, creating the 
Johnson and Wilson (JW) model (Henderson et al. 991-1003).  This assumption can be justified 
since only a small fraction of contrast agent is expected to cross the endothelial layer during the 
first pass through a capillary and no significant gradients will form (Garpebring, Östlund and 
Karlsson 1375-1383).  Consequently, the concentration of contrast agent in the EES is now only 
a function of time.  The main advantage of the JW model is that the equation set can now be 
closed; however, this can only occur in Laplace space (St. Lawrence and Lee 1365-1377).  The 
coupled differential equations and boundary conditions that govern the JW model are given as 
equations 1.15 – 1.19.  A visual representation of the JW model is given in Figure 1.3. 
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
"(#,)
"
=  −%
"(#,)
"#
 – [(', 	) −  (	)]   (1.15) 

"()
"
= +,
-
 . ((', 	) − (	))/'
-
0    (1.16) 
     (0, 	) =  (	)      (1.17) 
                   (' > 0,0) =  0       (1.18) 
     (0) = 0             (1.19) 
 
 
Figure 1.3 Johnson and Wilson Model1 
 
 
  
                                                 
1 Figure from Garpebring, Anders et al. "A Novel Estimation Method for Physiological Parameters in Dynamic 
Contrast-Enhanced MRI: Application of a Distributed Parameter Model using Fourier-Domain Calculations." IEEE 
Transactions on Medical Imaging 28.9 (2009): 1376. Print.  
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1.4 Adiabatic Approximation  
  
 In order to find a solution to the JW model in the time domain, an additional assumption 
is needed to simplify the equations.  The adiabatic approximation, proposed by Perl in 1979, 
states that the concentration of contrast agent within the EES will be constant over very short 
time periods (Garpebring, Östlund and Karlsson 1375-1383).  With the mathematical 
consequences of applying this approximation to the JW model fully derived by St. Lawrence in 
1998 and verified by Henderson in 2000, the Adiabatic Approximation of Johnson and Wilson 
(AAJW) model was formed (Henderson et al. 991-1003).  For the adiabatic approximation, the 
concentration of contrast agent in the EES will be represented by a stair step of constant values 
over small time increments.  If blood flow remains constant over the time interval and the system 
is linearly shift invariant, then the concentration of contrast agent in the EES will be a 
superposition of the concentration of contrast agent in the artery and a flow scaled impulse 
residue function (IRF), labeled as R(t) in equation 1.20 (Henderson et al. 991-1003).   
 
(	) =  (	)  ⊗ (	)             (1.20) 
 
 The IRF is a normalized function describing the uptake of a unit of contrast agent into the 
EES assuming instantaneous delivery to the capillary bed at the tissue of interest (Koh et al. 
1519-1538).  IRF curves are determined experimentally and encompass competing factors such 
as dispersion and recirculation; the AAJW method will work for any pharmacokinetic substance 
with an appropriately calibrated IRF (Henderson et al. 991-1003).  In general, the IRF for 
Gadolinium used in MRI is described by uptake of contrast agent until a critical time, 	, when it 
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is followed by an exponential decay as determined by parameters in equations 1.21 – 1.23.  The 
extraction ratio, , represents the flow and permeability of a particular vessel.  Stated differently, 
the extraction ratio is the fraction of contrast agent that passes from the plasma to the EES during 
a single pass through the capillary (Henderson et al. 991-1003).   
 
            (	) =  1                                  0 ≤ 	 ≤ 	            (1.21) 
(	) =   345 6 (47)/(9)   	 > 	               (1.22) 
      =  1 −  34+, (4: × <)/(6)                (1.23) 
 
 For the purposes of this study, the quantity (1 − = × >?	), also known as the fractional 
blood hematocrit, used in equation 1.23 is assumed to be a constant value for the time duration of 
the numerical experiment and valued at 0.72 (Henderson et al. 991-1003).  If (	) is known 
from an arterial input function, then the application of equations 1.20 – 1.23 allow for a simple 
calculation of contrast agent concentration in the EES using the convolution integral for a 
particular capillary. 
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CHAPTER 2 
MATERIAL 
 
2.1 Model Design 
 
 The fundamental approach used in the novel Krogh-Lattice (KL) model is to create 
physiology around imaging units, not vice-versa.  That is, a grid of image pixels is first 
established as the basis for the model.  Each image pixel then is populated with a uniform 
network of capillaries that communicate flow information to neighboring pixels.  Next, each 
pixel is assigned associated tissue parameter maps that allow localized tissue heterogeneity to be 
modeled.  Through simulation, the interaction of flow, diffusion, and tissue parameters are 
studied between plasma and EES compartments. 
 The fundamental object used in the KL model is a modified Krogh cylinder, called a 
capillary-tissue element (CTE).  The capillary-tissue element retains all previous properties of 
the Krogh cylinder, such as the EES and plasma compartments, but is simply scaled in length to 
microns.  Arrays of capillary-tissue elements are then connected together to simulate the 
movement of contrast agent in portions of the body.  Of interest, every capillary-tissue element 
has the ability to have a unique customization of parameters.  Rather than use one Krogh 
cylinder to represent an entire capillary, several capillary-tissue elements are connected in series 
to allow the insertion of diseased tissue locally and observation of the effect on the remainder of 
the capillary and slice of tissue.  Figures 2.1 and 2.2 allow visual comparison of a Krogh cylinder 
with an example series array of 4 capillary-tissue elements to represent the same capillary.   
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Figure 2.1 Krogh Cylinder as an Example Three Dimensional Capillary 
 
 
Figure 2.2 Capillary-Tissue Element Array as an Example Three Dimensional Capillary 
 
 To better represent two dimensional slices of tissue in MRI images, the three dimensional 
capillary-tissue element array of Figure 2.2 is flattened into a two dimensional version per Figure 
2.3.  Further, to increase the allowable density of capillary-tissue element arrays in the 
simulation and visually simplify identification of pairs of capillary-tissue elements, the KL 
model represents the EES on only one side of the capillary.  Figure 2.4 demonstrates this 
concept.  Next, the KL model aligns several simplified capillary-tissue element arrays into a 
 13 
 
lattice.  As shown in Figure 2.5, four capillary-tissue element arrays are arranged in parallel pairs 
and oriented in the cardinal directions.  This collection of capillary-tissue element arrays is 
named a capillary-tissue assembly (CTA).  To simplify the nomenclature of locations within a 
capillary-tissue assembly, the EES regions have been labeled north, south, east, and west.  This 
addition of multiple capillaries per pixel, as compared to a single Krogh cylinder used in the 
TCM, allows for more complex numerical experiments.  Any remaining grid locations within a 
capillary-tissue assembly are unused in the KL model and assumed to be cells. 
 
 
Figure 2.3 Two Dimensional Capillary-Tissue Element Array 
 
 
Figure 2.4 Simplified, Asymmetric Two Dimensional Capillary-Tissue Element Array 
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Figure 2.5 Example Capillary-Tissue Assembly with 12 × 12 units 
 
 The KL model incorporates both flow and diffusive methods of contrast agent transport.  
To deal with diffusion, grid elements of EES are placed along the outside of the capillaries, as 
described earlier and shown in Figure 2.5.  Within a capillary-tissue element, the mathematical 
relationship between the capillary contrast agent concentration and the EES contrast agent 
concentration is described by the AAJW convolution of equation 1.20.  At the interface between 
the capillary-tissue assemblies, only flow information is communicated via a finite difference 
scheme.  That is, all diffusion is restricted to within the individual capillary-tissue assembly and 
no contrast agent will diffuse across the boundaries. This assumption forms the basis of the 
AAJW model and corresponds with Krogh cylinder approximations (St. Lawrence and Lee 
1365-1377).  Further, advection of contrast agent within a capillary-tissue assembly also follows 
the finite difference scheme.  Conservation of contrast agent is applied within the advection and 
convolution steps of the simulation code.  Also, each grid point has an associated map of values 
that captures the important parameters of tissue.  These maps allow, for example, necrotic 
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regions within highly malignant tumors to be simulated as not taking up contrast agent due to 
local cell death. 
 Once several capillary-tissue assemblies are placed together, tissue slices can be 
represented and contrast distribution simulated.  This collection of capillary-tissue assemblies is 
named a capillary-tissue grid (CTG).  An example capillary-tissue grid is given as Figure 2.6.  In 
this example, a collection of 5 × 5 capillary-tissue assemblies are networked. 
 
 
Figure 2.6 Example Capillary-Tissue Grid with 5 × 5 Capillary-Tissue Assemblies  
and 120 × 120 Grid Units 
 
 
 
 
 
CTA 
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2.2 Parameters of Significance 
 
 With the AAJW properties of the KL model and equations 1.20 – 1.23, fortunately, there 
are only a few parameters of interest:   ,  (	), 	 ,  , , , (	),  and AIF(t).  For some of 
these, such as the volume fraction of EES,  , there exists a wealth of literature with tables of 
values for various types of tissue.   
 The IRF, (	), is described by equations 1.21 – 1.22.  The IRF depends on the 
parameters 	 , , , , and , all of which will be discussed here.  Based on the KL model 
incorporating transport of contrast agent, the critical time value of 	 is always set to zero.  In the 
generic AAJW model, 	 communicates the amount of time it takes for the initial bolus to pass 
through the capillary in a particular grid location.  Stated differently, 	 is the time that diffusion 
is parameter limited, or steady-state, based on the extreme concentration gradient from capillary 
to EES from the bolus.  Since this aspect of contrast agent transport is dealt with during the 
advection and convolution subroutines of the KL model, the information is still retained.  The 
remaining parameters that are not functions, , ,  and , are mathematically related by 
equation 1.23.   When applying equation 1.23, the parameters of PS and  are assumed to be 
constant for a particular tissue type, such as oxic cancer, on the spatial scale of the images 
simulated.  This leaves the parameter  to be calculated and then utilized in equation 1.21. 
 For the KL model, the arterial input function has been formed by multiplying two 
exponential functions and calibrated to match a particular set of experimental data (Strouthos et 
al. 1296-1310).  The arterial input function, AIF(t), is then applied as a source term in the 
capillary network, affecting the contrast agent concentration in capillary plasma, (	), based on 
the flow map. 
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 With some small adjustments in the KL model, the parameters of the AAJW model 
maintain their definitions.  For example, the volume fraction of the EES,  , represents the 
volume available to Gd contrast agent to occupy once it crosses the endothelial layer of the 
vasculature.  Since the KL model incorporates flow within and between capillary-tissue 
assemblies in a uniform lattice structure, the flow parameter of  incorporates the sub-resolution 
vasculature of a particular tissue.   
 In the KL model, control over the scale of the grid that numerical experiments are 
conducted upon is accomplished in two ways.  Each capillary-tissue assembly, and consequently 
each capillary-tissue grid, can have a customizable total number of units or grid points.  Next, the 
unit length of each grid location can be set to any scale desired.  In general, this unit length scale 
is 100 µm but can vary.  Likewise, the number of grid points is selected to best replicate the 
tissue slice being simulated. 
 
2.3 Code Development 
 
 The MATLAB© code used to conduct all numerical experiments is provided as Appendix 
A.  Using function and subroutine programming, the code is customizable for any desired 
numerical experiment with different capillary-tissue grid size, number of sources, flow fields, 
tissue parameters, etc.  Figure 2.7 provides a flowchart view of the code functionality. 
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Figure 2.7 Code Flowchart 
 
 Prior to the main program, several items are required to be initialized to save 
computational costs and provide input to the main program.  These include the dimensions of 
one capillary-tissue assembly (which will be later copied repeatedly to form the entire capillary-
tissue grid), the ending time of the simulation, the size of spatial and time steps, and the 
additional grid points (ghost points) required to perform finite difference calculations along the 
boundary of the image.  Healthy tissue parameters are assigned values and the files required to 
record a video of contrast agent distribution are established.  Based on the numerical experiment, 
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the number of capillary-tissue assemblies to be connected together in forming the capillary-tissue 
grid is assigned and populated.  Tissue parameter maps are then initialized to healthy values at 
all locations.  Simulation data maps, such as time to peak value, used to analyze the numerical 
experiment results, are set to zero until the experiments begin.  To simplify the inputs to the 
advection and convolution subroutines in the main program, grid locations are identified and 
stored where each capillary-tissue assembly starts along the x and y directions.  Further, the EES 
elements within each capillary-tissue assembly are also identified and stored by their cardinal 
locations.  Next, source locations within the capillary-tissue grid are established as inputs to the 
main program.  If desired, tissue parameter maps are then modified to insert malignant tissue at 
any grid location. 
 Within the main program, several subroutines are called through hundreds of iterative 
time steps.  Initial conditions place the arterial input function, or source of contrast agent, in the 
appropriate locations passed to it as inputs.  Boundary conditions are set to zero, simulating that 
contrast agent reaching the edges of the image is allowed to flow outside the field of view.  Next, 
the convolution operation of equation 1.20 is applied to each capillary-tissue element.  By 
identifying which compartment is higher in concentration, either plasma or EES, the correct 
impulse residue function is utilized and contrast is diffused appropriately.  Additionally, 
simulation data sets for later analysis are populated during this step such as maximum contrast 
agent concentration.   
 After the diffusive aspect of contrast agent movement is simulated, the bulk advection of 
blood flow within the capillaries is performed.  For the finite difference scheme of bulk transport 
in the KL model, movement of contrast agent is treated with a third-order, explicit, forward-time, 
centered-space, Takacs scheme (Takacs 1050-1065).  Although odd-order finite difference 
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methods can cause significant gradients at boundaries, the number of time steps required to 
simulate an image signal at high temporal resolution prohibits the dispersive effects of an even-
order scheme, such as Lax-Wendroff (Duran 35-106).  Advection is performed by identifying the 
rows and columns where capillaries exist, copying that particular set of simulation data as a one 
dimensional array, performing a one dimensional Takacs advection process, and then copying 
the advected simulation data back to the original image per a directionally split scheme.  This 
method of fractional steps, where two dimensional advection is dealt with by applying and 
alternating the order of one dimensional advection (x or y), maintains numerical stability and 
prevents specious solutions due to two dimensional flow vector cross-products (Duran 35-106).  
Filters are then applied to simulation data sets to prevent instabilities from forming due to 
mathematical operations with near-zero values by setting them to zero.  The remaining 
subroutines pull various information from the capillary-tissue grid for simulation data analysis 
including contrast agent concentration at the current time step in the form of a history array.  
Lastly, desired simulation data is plotted and stored for later use before the next time iteration is 
begun. 
 All simulations were run on MATLAB©  2010b software using original code.  The 
program was executed on a M1530 XPS Dell© laptop with 2.4 GHz Intel© Core Duo CPU, 4 GB 
of RAM, and using Windows© Vista 32-bit.  Tissue slices were assumed to be breast tissue with 
corresponding parameter maps for sarcoma studies.  Code functionality was demonstrated using 
two methods.  First, periodic boundary conditions were established with a unit of contrast agent 
administered such that contrast agent concentration became uniform across the entire grid.  Next, 
a constant source value numerical experiment was performed to demonstrate that a steady-state 
solution develops. 
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2.4 Hypothesis 
 
 Through simulating the effects of sources, tissue heterogeneity, and the contribution of 
individual tissue parameters to an image, the Krogh-Lattice model demonstrates the effects of a 
priori flow maps on image contrast.  Specifically, the model attempts to show that flow 
information is as important as permeability data when analyzing tumor contrast enhancement.  
By acquiring both flow and permeability data, it may be possible to obtain tumor-type diagnostic 
information in vivo.   
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CHAPTER 3 
METHODS 
 
3.1 General Numerical Experiment Setup 
 
 For all numerical experiments, the capillary-tissue grid is formed with a 6 × 6 capillary-
tissue assembly matrix consisting of 144 × 144 units.  Each grid unit is calibrated to a width of 
100 µm.  Within the capillary-tissue grid, each capillary-tissue assembly is to represent one pixel 
of a MRI image and each is labeled with an identification number.  This is demonstrated in 
Figure 3.1. 
 
 
Figure 3.1 Numerical Experiment Capillary-Tissue Grid with  
6 × 6 Capillary-Tissue Assemblies (Labeled) and 144 × 144 Units 
 
1 2 3 4 5 6 
7 8 9 10 11 12 
13 14 15 16 17 18 
19 20 21 22 23 24 
25 26 27 28 29 30 
31 32 33 34 35 36 
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 The AIF, as a contrast agent source, is admitted somewhere into the tissue and later exits.  
Flow is always along the diagonal direction, from the bottom left of the tissue slice towards the 
upper right.  This assumption allows other aspects of imaging, such as tissue parameter maps of 
section 2.2, to be isolated for study.  The imaging period is limited to 40 seconds since the first 
pass of contrast agent is assumed to occur during this time.  The finite difference model is run in 
0.1 second increments, for a total of 400 time steps.  This discrete time unit was experimentally 
determined to have enough resolution to maintain contrast agent flow as smooth, preventing 
wave packets, while maintaining moderate computational cost.  In addition, contrast agent that 
reaches the boundary of the capillary-tissue grid is allowed to leak out and is lost from the image.  
This assumption means that all flow is maintained in a two dimensional plane but can freely 
communicate with neighboring in-plane tissue slices.  For the purposes of this study, the cancer 
is assumed to be oxic, hypoxic, or necrotic breast tissue sarcoma.  The parameters used in the 
study for oxic cancer are provided as table 3.1 as found in the literature (Henderson et al. 991-
1003).  Healthy muscle tissue parameters are also readily available in recent research (Kershaw 
and Buckley 986-992).  For necrotic tissues, all parameters were set to zero or near-zero values 
to prevent undefined mathematical operations.  The hypoxic cancer values of table 3.1 are linear 
extrapolations between oxic cancer and necrosis obeying equation 1.23 (Murase and Miyazaki 
2791-2805). 
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Parameter Healthy Tissue Oxic Sarcoma Hypoxic Sarcoma Necrotic Tissue 
ve   0.08 0.45 0.23 0.01 
Fp   (min
-1) 0.06 0.28 0.14 0 
E 0.42 0.49 0.49 0 
PS  (min-1) 0.05 0.26 0.13 0 
 
Table 3.1 Tissue Parameters Used (Henderson et al. 991-1003; Kershaw and Buckley 986-992) 
 
 Numerical experiments are comprised of two parts, A and B.  In general, part A provides 
a known flow map in healthy tissue.  Part B will have one major difference, such as the addition 
of an oxic tumor, but otherwise be similar to part A.  These two parts aid in identifying results of 
flow mapping across a large simulation data set and comparing it to other numerical 
experiments.  Several computations are performed on a unit-by-unit basis and mapped back to 
the original image such as peak contrast concentration.  These resulting computational maps then 
can be subtracted from one another (part A from part B), condensing two sets of 144 (grid units) 
× 144 (grid units) × 400 (time steps) arrays into a single image to visually and mathematically 
compare differences.  That is, a simulation data set with a tumor present can be subtracted by the 
underlying flow map data set to reveal and isolate the effect of the tumor on the final image. 
 In particular, the following calculations were performed for each unit of the tissue slice to 
determine simulation data maps of interest: the integral of the contrast agent signal over the 
numerical experiment time (or area under the curve), the peak value of contrast agent, the time 
when the peak value of contrast agent is obtained, the time when the contrast agent first arrives, 
and a linear approximation of the slope of the contrast agent signal from the first nonzero value 
until reaching the maximum value.    
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3.2 Numerical Experiment Methodology 
 
 To fully investigate the hypothesis of section 2.4, seven sets of numerical experiments 
were performed:  model validation, multiple sources in healthy tissue, multiple sources in 
malignant tissue, malignant tissue with hypoxia and necrosis, distance of tumors from sources, 
significance of tissue parameters, and unique tissue geometries.  These numerical tests are 
described below.  Results of these numerical experiments are given in chapter 4.  A summary of 
all experiments and resulting images is given as table 3.2. 
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Experiment 
Set 
Study 
Numerical 
Experiment 
Methods 
Figures 
Results 
Figures 
1 Model Validation 1, 2 3.2, 3.3 
4.1, 4.2, 4.3, 
4.4, 4.5, 4.6 
2 
Multiple Sources in Healthy 
Tissue 
3, 4 3.4, 3.5 4.7, 4.8, 4.9 
3 
Multiple Sources in 
Malignant Tissue 
5, 6, 7, 8 
3.6, 3.7, 
3.8, 3.9 
4.10, 4.11, 
4.12, 4.13 
4 
Malignant Tissue with 
Hypoxia and Necrosis 
9, 10, 11 
3.10, 3.11, 
3.12 
4.14, 4.15, 
4.16, 4.17 
5 
Distance of Tumors From 
Sources 
12, 13, 14 
3.13, 3.14, 
3.15 
4.18, 4.19, 
4.20, 4.21, 
4.22, 4.23, 
4.24 
6 
Significance of Tissue 
Parameters 
15, 16, 17, 
18, 19, 20 
3.16, 3.17, 
3.18, 3.19, 
3.20, 3.21 
4.25, 4.26, 
4.27, 4.28, 
4.29, 4.30 
7 Unique Tissue Geometries 21, 22, 23 
3.22, 3.23, 
3.24 
4.31, 4.32, 
4.33, 4.34, 
4.35, 4.36 
 
Table 3.2 Summary of Numerical Experiments 
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 In the first set of tests, the model will be validated with numerical experiment 1.  This 
describes a simple, source-addition in healthy tissue as shown in Figure 3.2.  Additionally, model 
validation will be conducted on a complex tumor for numerical experiment 2 in Figure 3.3.  Both 
tests serve as a control for future a priori numerical experiments since flow is assumed to be zero 
in each.   
 
 
Figure 3.2 Numerical Experiment 1 – Addition of Sources to a Zero Flow Map 
 
 
Figure 3.3 Numerical Experiment 2 – Addition of Tumor and Sources to a Zero Flow Map 
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 For the second study, multiple sources will be added, moved, and compared to a known 
source configuration for wholly healthy tissues.  These correspond to numerical experiments 3 
and 4 with Figures 3.4 and 3.5 respectively.  The goal with this sequence of testing is isolate the 
effects of adding a source to a known flow map.  Stated differently, the effects of only having a 
partial flow map are analyzed.   
 
 
Figure 3.4 Numerical Experiment 3 – Addition of One Source to Known Flow Map 
 
 
Figure 3.5 Numerical Experiment 4 – Alternate Addition of Sources to Known Flow Map 
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 Third, healthy tissue will be compared to oxic cancer tissue while again moving sources 
as seen in Figures 3.6, 3.7, 3.8, and 3.9.  These Figures correspond to numerical experiments 5, 
6, 7, and 8.  For this set of tests, the goal is to determine any identifying characteristics of oxic 
cancer with known flow maps.  These characteristics should be observed in the diseased pixels 
but may also be found in healthy pixels downstream of malignant tissue.   
 
 
Figure 3.6 Numerical Experiment 5 – Addition of Tumor to Known, Single Source Flow Map 
 
 
Figure 3.7 Numerical Experiment 6 – Addition of Oxic Tumor to Known, Dual Source Flow 
Map 
 
 30 
 
 
Figure 3.8 Numerical Experiment 7 – Addition of Oxic Tumor to Known, Three Source Flow 
Map 
 
 
Figure 3.9 Numerical Experiment 8 – Addition of Tumor to Known, Alternate Three Source 
Flow Map  
 
 In the fourth set of numerical experiments, the cancer will be modified to include hypoxic 
and necrotic regions as in Figure 3.10, 3.11, and 3.12.  These Figures correspond to numerical 
experiments 9, 10, and 11.  The goal is to observe how the different forms of malignant tissue 
vary in contrast agent uptake for known flow maps.  Specifically, identification of the type of 
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malignant tissue by differing characteristics between oxic, hypoxic, and necrotic regions is 
examined. 
 
 
Figure 3.10 Numerical Experiment 9 – Addition of Hypoxic Region to Tumor With Known Flow 
Map 
 
 
Figure 3.11 Numerical Experiment 10 – Addition of Necrosis to Tumor with Known Flow Map 
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Figure 3.12 Numerical Experiment 11 – Addition of Necrosis to Tumor With Known, Alternate 
Flow Map 
 
 In the fifth sequence, oxic cancer is moved to various distances from a source to attempt 
to reduce the contrast agent uptake signal.  Figures 3.13, 3.14, and 3.15 correspond to numerical 
experiments 12, 13, and 14 respectively.  The goal of these tests is to measure the effect of 
source proximity on the image signal of cancerous areas.  The magnitude of signal difference for 
the same sized oxic tumor placed upstream, downstream, or remote from a source network 
should change accordingly. 
 
 
Figure 3.13 Numerical Experiment 12 – Tumor Location Study Adjacent Known Flow Map 
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Figure 3.14 Numerical Experiment 13 – Alternate Tumor Location Study Adjacent Known Flow 
Map 
 
 
Figure 3.15 Numerical Experiment 14 – Remote Tumor Location Study with Known Flow Map 
 
   For the sixth set of numerical experiments, individual cancer parameters of interest are 
inserted into healthy tissue to perform a parameter significance study.  The goal is to determine 
which factor, ,  or , contributes most in forming the contrast agent uptake curve.  
Specifically, a symmetric portion of healthy tissue has one parameter changed, such as EES 
volume fraction (), to a malignant value and the numerical experiment is run.  These tests are 
Figures 3.16, 3.17, 3.18, 3.19, 3.20, and 3.21.  The corresponding numerical experiments are 15, 
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16, 17, 18, 19, and 20.  By identifying the tissue parameter that is most significant, insight can be 
gained into how oxic versus hypoxic tumors will image.   
 
 
Figure 3.16 Numerical Experiment 15 – Oxic Tumor Compared to Healthy Tissue  
with One Malignant Parameter, ve, with Known Flow Map 
 
 
Figure 3.17 Numerical Experiment 16 – Oxic Tumor Compared to Healthy Tissue  
with One Malignant Parameter, Fp, with Known Flow Map 
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Figure 3.18 Numerical Experiment 17 – Oxic Tumor Compared to Healthy Tissue  
with One Malignant Parameter, E, with Known Flow Map 
 
 
Figure 3.19 Numerical Experiment 18 – Healthy Tissue Compared to Healthy Tissue  
with One Malignant Parameter, ve, with Known Flow Map 
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Figure 3.20 Numerical Experiment 19 – Healthy Tissue Compared to Healthy Tissue  
with One Malignant Parameter, Fp, with Known Flow Map 
 
 
Figure 3.21 Numerical Experiment 20 – Healthy Tissue Compared to Healthy Tissue  
with One Malignant Parameter, E, with Known Flow Map 
 
 Lastly, the seventh set of numerical experiments tests some unique geometries of oxic 
cancer to attempt to find the best simulation data set to discern cancer from healthy tissue.  
Figures 3.22, 3.23, and 3.24 correspond to numerical experiments 21, 22, and 23 respectively.  
First, a series of tumors in the form of columns are created to investigate any downstream 
characteristics in the healthy tissue portions that may identify upstream cancer.  Then, sub-
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resolution cancer is inserted and analyzed from two perspectives.  In the first point of view, each 
grid location is assumed to be resolvable and the effect of a small tumor is analyzed for the 
ability to be detected.  In the second approach, the tumor is assumed to be below the resolution 
of the MRI equipment.  The healthy and malignant parameters, for that image pixel, are averaged 
and the reduced signature is analyzed.  The goal of this final numerical experiment is to identify 
any characteristics that can be utilized to identify the presence of sub-resolution tumors. 
  
 
Figure 3.22 Numerical Experiment 21 – Unique Oxic Tumor Geometry with Known Flow Map 
 
 
Figure 3.23 Numerical Experiment 22 – Alternate Unique Oxic Tumor Geometry with Known 
Flow Map 
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Figure 3.24 Numerical Experiment 23 – Repeat of Numerical Experiment 22 with Oxic Cancer  
Parameters Averaged over Pixel 8 
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CHAPTER 4 
RESULTS 
 
4.1 Model Validation 
  
 To validate the model, numerical experiment 1 was performed.  Overall, this trial 
demonstrates imaging simulation data results if the flow map is assumed to be zero for a simple 
source configuration.  Specifically, two sources within healthy tissue are compared to a healthy 
tissue slice with no sources.  Figure 4.1 represents the difference of the integrated signal per grid 
unit in part B of numerical experiment 1 from the integrated signal per grid unit in part A of 
numerical experiment 1.   
 
 
Figure 4.1 Numerical Experiment 1 – Two Sources Observed 
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 This visualization of the difference in the two simulation data sets demonstrates that the 
sources dominate the integrated signal.  The underlying tissue remains unchanged and does not 
contribute significantly to the image.  Per Figure 4.2, the time elapsed before a local grid unit 
reaches its peak value of contrast agent concentration (time of peak) is linearly increasing across 
the grid for the EES units as the EES is located farther from a source.  That is, only the EES 
retains contrast agent for any sustained period of time since the capillary concentration is subject 
to bulk advection.  Flow can also be visualized as the time elapsed until a given grid location has 
a nonzero contrast agent value, as shown in Figure 4.3.  Therefore, there is a steady and linear 
increase along the diagonal axis of flow. 
 
 
Figure 4.2 Numerical Experiment 1 – EES Retention of Contrast Agent 
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Figure 4.3 Numerical Experiment 1 – Flow From Origin Towards Upper-Right  
 
 As the next step to validate the model, numerical experiment 2 was performed.  In this 
case, a tumor with oxic and hypoxic regions is inserted along with multiple sources as compared 
to uniform, source-less healthy tissue.  This trial again tests the imaging result if flow maps are 
assumed to be zero.  In the resulting simulation data, the sources dominate the integrated signal 
as seen in Figure 4.4 and the presence of cancer is lost.  The time of peak, however, is able to 
discern malignant tissue in Figure 4.5.  Upon closer review, oxic and hypoxic regions appear 
similar without the flow information and are only emphasized for EES units.  Lastly, Figure 4.6 
provides another way to visualize flow and location of sources. 
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Figure 4.4 Numerical Experiment 2 – Three Sources Observed, No Indication of Tumor 
 
 
Figure 4.5 Numerical Experiment 2 – Malignant Tissue Detected in EES Via Time of Peak 
Signal, No Differentiation of Tumor Type 
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Figure 4.6 Numerical Experiment 2 – Detection of Source at Top-Center 
 
 In this sequence of testing, a few conclusions can be drawn.  First, a source located 
within the tissue slice being imaged will tend to saturate the resulting simulation data related to 
signal intensity.  This effect encompasses the integrated signal value, the peak value, and the 
initial slope of the signal.  If the flow map is not known, then this “washout” of the underlying 
tissue information will prevent cancer from being detected via this method.  Diseased tissue can 
be found, however, by measuring the time elapsed until a peak value is reached and comparing 
that to known healthy tissue.  Without flow information, however, all grades of cancer will 
appear similar and only offer a small threshold difference in time for detection.   
 
4.2 Multiple Sources in Healthy Tissue 
 
 To study the effects of sources in entirely healthy tissue, several sets of trials were 
performed.  In numerical experiment 3, a source is added to a known flow map and the effect 
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measured.  The addition of the extra source in healthy tissue, as shown in Figure 4.7, has the 
expected result of increased flow downstream and no effect upstream as compared to the original 
image.  Note that this numerical experiment contains a partial flow mapping effect, where all 
upstream grid locations in Figure 4.7 are zero due to the subtraction operation between the part A 
and part B simulation data sets.   
 
 
Figure 4.7 Numerical Experiment 3 – Detection of Additional Source With Upstream Partial 
Flow Mapping Effect  
 
 Numerical experiment 4 then tests the addition of two sources to a known flow map.  
When one of the new sources is added to the center of the tissue slice, per Figure 4.8 and 4.9, 
complexities become apparent.  The central source in pixel 22 appears as clearly as the source in 
pixel 2 from the integrated signal approach.  The time of the first nonzero value of contrast 
agent, however, yields different results.  The source in pixel 2 causes a small downstream effect 
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while the source in pixel 22 has almost three times the intensity of an effect.  Specifically, the 
time to reach a nonzero value for a grid location will occur sooner for those downstream tissues 
near a source. 
 
 
Figure 4.8 Numerical Experiment 4 – Detection of Two Additional Sources 
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Figure 4.9 Numerical Experiment 4 – Proximity Dependence of Sources on Time of First 
Nonzero Contrast Agent Value 
 
 The addition of multiple sources to a partial flow map can yield varying flow effects on 
the simulation data sets.  Specifically, the intensity of the effect will be related to the proximity 
of the new sources to the known partial flow map.  In short, the application of flow maps 
necessitates that they be accurate to yield any useful information. 
 
4.3 Multiple Sources in Malignant Tissue 
 
 In the third set of numerical experiments, sources previously applied to healthy tissues 
are applied to oxic sarcoma tissue.  Figure 4.10 demonstrates the difference between integrated 
signals for oxic cancer and healthy tissue in a constant source configuration per numerical 
experiment 5.  The time-to-peak shift can be observed in Figure 4.11 for the same numerical 
experiment.  With the flow maps in place, the diseased tissue is easily identified and 
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corroborated.  When two sources are present that are external to the tumor, as in numerical 
experiment 6, a comparison study reveals a very similar integrated signal and time-to-peak map.   
 
 
Figure 4.10 Numerical Experiment 5 – Detection of Malignant Tissue With Flow Maps 
 
 
Figure 4.11 Numerical Experiment 5 – Confirmation of Malignant Tissue 
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 If a third source is added and is located internal to the tumor, as in numerical experiment 
7, a larger integrated signal can be found locally near the source.  This is apparent in Figure 4.12 
and could lead to misdiagnosis of a smaller region of cancer if the signal intensity scale is not 
considered.  Of note, across numerical experiments 5 through 7, the time-to-peak simulation data 
remains similar and is shown as Figure 4.13.  This is due to the fact that the sources of flow are 
known, constant values.   
 
 
Figure 4.12 Numerical Experiment 7 – Detection of Malignant Tissue With Internal Source 
Saturating Neighboring Oxic Sarcoma Signal 
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Figure 4.13 Numerical Experiment 7 – Confirmation of Malignant Tissue 
 
 The presence of cancer causes a larger initial contrast agent concentration peak followed 
by a faster rate of decay as compared to healthy tissue.  The malignant tissue is effectively more 
porous and vascular such that it readily transfers contrast agent.  Sources located within tumors 
may yield a saturating image signal that masks neighboring cancer.  This implies that vasculature 
geometry and flow rate affects tumor permeability measurements.  This could lead to poor 
characterization of tumor tissue.  Prediction of an exaggerated peak value in malignant tissue is 
best emphasized for diseased pixels near the source.  There is also a corresponding time of peak 
shift as compared to healthy tissue.  The time of peak shift is fairly consistent but can become 
muddled as some MRI schemes require several seconds of time to measure the signal, yielding 
an averaging effect (Liang 57-106).   
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4.4 Malignant Tissue with Hypoxia and Necrosis 
 
 To further examine the interaction between flow and PS, tissue heterogeneity is 
introduced.  This complication will aid in determining if downstream effects of the tissue are 
significant in masking or emphasizing the presence of cancer.  Again, a known flow map is 
applied to all trials.  In numerical experiment 9, a tissue slice with oxic and hypoxic cancer is 
compared to a completely healthy tissue slice with similar source terms.  Figure 4.14 
demonstrates the reduced uptake of contrast agent in the hypoxic region.  Noting that the oxic 
tissue is spatially dependent on source location and hence flow, areas distal to the source yield 
similar integrated signal value as the central hypoxic area.  It is difficult to determine type of 
cancer with a threshold filter in this case.  Further, the time-to-peak in Figure 4.15 is nearly 
identical across the entire tumor but does exhibit a one second difference for hypoxic pixels. 
 
 
Figure 4.14 Numerical Experiment 9 – Detection of Malignant Tissue With Hypoxic Sarcoma at 
Center of Tissue Appearing Similarly as Distal Oxic Sarcoma 
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Figure 4.15 Numerical Experiment 9 – Differentiation of Oxic and Hypoxic Sarcoma With Time 
of Peak Simulation Data 
 
 In numerical experiment 11, an off-axis source provides contrast agent for a larger tumor 
containing hypoxic and oxic regions.  Figures 4.16 and 4.17 show the resulting simulation data 
sets.  Based on distance from the source, some oxic cancer regions appear as nearly zero as well 
as most hypoxic pixels.  With this lack of contrast, the time of peak simulation data is also 
affected such that all non-necrotic cancerous pixels appear similar.  Since the necrotic pixel 
never draws contrast agent out of the capillary, it exhibits a large negative value for time of peak 
as compared to a healthy tissue slice and is easily identified. 
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Figure 4.16 Numerical Experiment 11 – Detection of Malignant Tissue With Hypoxic and 
Necrotic Sarcoma at Center of Tissue Appearing Similarly as Distal Oxic Sarcoma 
 
 
Figure 4.17 Numerical Experiment 11 – Differentiation of Necrotic and Other Malignant Tissue 
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 From this set of studies, a few key points can be drawn.  First, hypoxic cancer located on-
axis of the flow vector exhibits a reduced uptake of contrast agent.  This is expected as higher 
flow tissue (i.e. the local tissue receives more contrast) allows for increased diffusion.  However, 
the hypoxic areas can be confused with healthy tissue due to off-axis effects.  Secondly, necrotic 
regions do not have a significant effect on downstream tissues.  Instead, the more significant 
finding is that a single pixel offset of the source from the main flow vector axis can yield 
integrated contrast agent values to be near zero in many pixels.  In particular, Figure 4.16 could 
be misinterpreted as a tissue slice having cancer only in the region closest to the origin, such as 
pixels 7 and 8.  Simultaneously, with this reduced uptake of contrast agent in pixels due to an 
off-axis source, the time to peak information previously enabling the differentiation of cancer 
type is now suppressed.  Although it is obvious that some form of malignant tissue is present 
from Figure 4.16, the most significant effect is the zero uptake of the necrotic region. 
 
4.5 Distance from Sources 
 
 To test the spatial dependence of sources and tissue types, oxic cancer was moved to 
various locations relative to source pixels to measure the change in contrast agent signal 
response.  In numerical experiments 12 and 13, the contrast agent uptake is tested for a pixel of 
cancer placed immediately before or after a source location along the flow vector.  As seen in 
Figures 4.18 – 4.21, there are no significant changes for such a minor cancer locality difference.   
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Figure 4.18 Numerical Experiment 12 – Detection of Localized Malignant Tissue 
 
 
Figure 4.19 Numerical Experiment 12 – Confirmation of Malignant Tissue 
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Figure 4.20 Numerical Experiment 13 – Detection of Localized Malignant Tissue 
 
 
Figure 4.21 Numerical Experiment 13 – Confirmation of Localized Malignant Tissue 
 
 In numerical experiment 14, however, a pixel of oxic cancer is successfully masked from 
the image by locating it remotely downstream and off-axis of a source.  This is demonstrated in 
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Figures 4.22 – 4.24.  Noting the scale of the images, the response of contrast agent could easily 
be confused as noise. 
 
 
Figure 4.22 Numerical Experiment 14 – Inability to Detect Malignant Tissue Remote From 
Source With Integrated Contrast Agent Values 
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Figure 4.23 Numerical Experiment 14 – Inability to Detect Malignant Tissue Remote From 
Source With Peak Contrast Agent Values 
 
 
Figure 4.24 Numerical Experiment 14 – Inability to Detect Malignant Tissue Remote From 
Source With Time of Peak Contrast Agent Values 
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 As expected, this sequence of testing supports that dynamic contrast enhanced MRI of 
cancer requires a source to be located upstream in order to obtain an image.  While this statement 
is fairly straightforward, the incorporation of results from sections 4.2 and 4.3 can present 
complications in understanding a final image.  Said differently, the clinician must work 
backwards from an image result to interpret the contrast agent signal as tissue parameters.  A 
region of low contrast agent uptake could be healthy tissue, a spurious result from an incorrect 
flow map, or simply an area of malignant tissue located far enough downstream of the flow 
network. 
 
4.6 Significance of Tissue Parameters 
 
 To help understand the effects of each factor contributing to contrast agent uptake, a 
parameter study using the AAJW method was performed.  In numerical experiment 18, healthy 
tissue is modified with an increased EES volume fraction that corresponds to oxic cancer.  Flow, 
vascularity, and extraction ratios remained constant at healthy tissue values.  Figures 4.25 and 
4.26 reveal the results.  With only minor effect, this study reveals a small increase in integrated 
contrast agent over time and no effect on the flow reaching other regions of tissue.  These results 
support that a larger volume in the EES, to hold contrast agent, allows for a greater concentration 
to form before osmotic pressure equalizes with the concentration within the capillary. 
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Figure 4.25 Numerical Experiment 18 – Detection of Malignant Tissue With Increased EES 
Volume Fraction Via Integrated Contrast Agent Signal 
 
 
Figure 4.26 Numerical Experiment 18 – Inability to Detect Malignant Tissue With Increased 
EES Volume Fraction Via Time of First Nonzero Contrast Agent Signal 
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 Next, numerical experiment 19 was performed to see if increased vascularity had a 
significant effect on otherwise healthy tissue.  From Figures 4.27 and 4.28, it is clear that this 
parameter has a much greater effect on the integrated signal and results in an image of the same 
form as an oxic tumor.  The increased local blood flow provides the strongest result and is 
characteristic of a malignant tumor.   
  
 
Figure 4.27 Numerical Experiment 19 – Detection of Malignant Tissue With Increased Tumor 
Vascularity Via Integrated Contrast Agent Signal 
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Figure 4.28 Numerical Experiment 19 – Confirmation of Malignant Tissue With Increased 
Tumor Vascularity Via Time of Peak Contrast Agent Signal 
 
 In numerical experiment 20, the extraction ratio is studied as applied to otherwise healthy 
tissue.  Figures 4.29 and 4.30 show the extremely limited effect.  Of note, the value of the 
extraction ratio is not significantly different between healthy and oxic cancer tissues per table 
3.1. 
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Figure 4.29 Numerical Experiment 20 – Inability to Detect Malignant Tissue With Increased 
Tumor Extraction Ratio Via Integrated Contrast Agent Signal 
 
 
Figure 4.30 Numerical Experiment 20 – Inability to Detect Malignant Tissue With Increased 
Tumor Extraction Ratio Via Time of First Nonzero Contrast Agent Signal 
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4.7 Unique Tissue Geometries 
 
 To test the extremes of the KL model, a few special cases of cancer geometry were 
studied.  In numerical experiment 21, several columns of oxic cancer were placed equidistant 
throughout the tissue slice and contrast agent uptake was measured.  Figures 4.31 and 4.32 reveal 
the results.  The pixels of diseased tissue furthest from the source demonstrate reduced uptake of 
contrast agent.  The time-to-peak, however, reveals similar values for all cancerous regions.  
Also, the regions between the cancerous columns have a small depression in peak times that 
could be misinterpreted as cancer.  This effect can be explained by the upstream cancerous pixels 
drawing out more contrast agent than in the healthy case.  With this in mind, the downstream 
healthy tissue has less contrast agent available and therefore reaches a peak at a later time.   
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Figure 4.31 Numerical Experiment 21 – Source Proximity Effects on Detection of Malignant 
Tissue  
 
 
Figure 4.32 Numerical Experiment 21 – Detection of Malignant Tissue Via Time of Peak 
Contrast Agent Signal 
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 Next, oxic cancer is inserted in the north region of pixel 8 in a sub-resolution fashion as 
numerical experiment 22.  This trial demonstrates the behavior of contrast agent assuming sub-
voxel heterogeneity.  Figures 4.33 and 4.34 reveal the characteristic results of cancer.   
 
 
Figure 4.33 Numerical Experiment 22 – Detection of Malignant Tissue at Sub-Voxel Resolution 
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Figure 4.34 Numerical Experiment 22 – Confirmation of Malignant Tissue at Sub-Voxel 
Resolution 
 
 In numerical experiment 23, oxic cancer is inserted in the same fashion as the last 
numerical experiment.  The pixels, however, are averaged over the internal area to replicate MRI 
resolution and the resulting averaged signal.  Figures 4.35 and 4.36 show the differences at this 
level of resolution.  Of note, the same type of effect, a reduced signal magnitude of 
approximately 50%, is apparent in both simulation data sets.  It is not entirely clear that a 
threshold filter could detect this small tumor, depending on noise levels and the time averaging 
taking place during imaging.  It is true, however, that downstream tissues are not greatly affected 
by a small lesion and it is difficult to draw any conclusions from their contrast agent uptake.   
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Figure 4.35 Numerical Experiment 23 – Weak Detection of Malignant Tissue at Sub-Voxel 
Resolution With Averaging 
 
 
 
Figure 4.36 Numerical Experiment 23 – Weak Detection of Malignant Tissue at Sub-Voxel 
Resolution With Averaging 
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CHAPTER 5 
DISCUSSION 
 
5.1 Flow and Diffusion Assumptions  
 
 The Krogh-Lattice model uses a uniform blood flow vector during advection and is a 
gross simplification to allow isolation of other effects.  Further, all flow of contrast agent is 
restricted into a two dimensional plane.  These assumptions are designed to enable the 
examination of flow mapping on tumor diagnosis and are required for this phase of 
experimentation.  As demonstrated in chapter 4, these assumptions reveal significant results 
regarding consistent time-to-peak identification of malignant tissue.   
 The validity of a particular arterial input curve, AIF(t), is still subject to much debate 
(Voltairas et al. 1423-1431).  As an added complication, contrast agent is traditionally 
administered via a vein prior to reaching the arterial system and downstream capillaries.  Further, 
the rate of administration of contrast agent as a bolus can significantly change the AIF curve 
(Bae 809-816).  Lastly, most models represent blood flow at the capillary scale as constant 
velocity versus the more physiological pulsatile flow.  This is worthy of separate and focused 
study but was not modeled here. 
   Based on Krogh cylinder approximations, the KL model prohibits diffusion from taking 
place between EES elements and across capillary-tissue assembly boundaries.  This 
simplification of conservation of contrast agent is valid for situations where flow is dominant 
over diffusion effects.  For all numerical experiments performed, this requirement is met and can 
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be observed by comparing the magnitudes of Figures 4.25 and 4.27 as representations of each 
contribution.   
 
5.2 Sources and Physiology 
 
 Across the numerical experiments, the key to understanding how cancer would image is 
having an accurate flow map prior to administering contrast agent.  This is a procedure in some 
forms of imaging, such as diffusion weighted MRI, but not exclusively practiced (Shimony, Lee 
and Bretthorst 535-542).  Further, due to tumor vascular heterogeneity, it may be difficult to 
identify all sources of tumor blood flow.  These missed sources that subsequently provide 
contrast may cause errors in recognizing malignant tissue.  As observed in numerical experiment 
7 and Figure 4.12, source location has a strong effect on integrated signal values and the ability 
to resolve heterogeneous tissue slices.  Thus, with the results of section 4.2, flow sensitive 
imaging must incorporate all sources.  In either case of flow maps being known or assumed to be 
zero, the time-to-peak map is able to detect malignant tissue.  Per numerical experiment 9 and 
Figure 4.15, where flow is known a priori, time-to-peak can even resolve hypoxic versus oxic 
cancer.  Further, the vascularity factor tested in numerical experiment 19 appears to dominate 
other parameter maps as the characteristic contrast agent response for cancerous tissues.  This is 
supported in the literature for many types of malignant tissue (Sahani et al. 785-792).  Ignored in 
this study, the chemical interaction of water and Gadolinium is an active field of research and 
should be incorporated given the scale of the simulations (Yazyev et al. 10997-11005).     
 A few of the numerical experiment setups with necrosis could be improved with 
physiologically based source locations.  In general, necrotic regions are farther from a source 
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than oxic areas.  Likewise, hypoxic regions would be located more distant to a source than oxic 
tissues.  For a single source numerical experiment, such as experiment 10 shown in Figure 3.11, 
the necrotic regions would need to be located in pixel 36.  As performed, however, the test has 
value and demonstrates the importance of having a known flow map. 
 
5.3 Simulation Data Sets 
 
 By connecting a series of capillary-tissue elements together obeying the AAJW model, 
insight towards the more complex Tissue Homogeneity model is gained.  That is, the segments 
of EES within a series of capillary-tissue elements now provide contrast agent concentration as a 
function of time and a discrete version of space.  This point is not expanded, however, by 
running similar numerical experiments with different numbers and appropriately scaled 
capillary-tissue elements. 
 In the numerical experiments, some of the simulation data sets yielded little useful 
information.  Numerical experiment 20, where the effect of the extraction ratio is studied, is 
difficult to interpret because of the relationships between , ,  and  per equation 1.23.  Due 
to the assumptions of section 2.2, it is not possible to isolate  from  and  within the KL 
model.  Further, it was determined that the parameter map of peak values of contrast agent was 
almost always similar to the integrated signal map but offered less intensity in contrasting 
images.  For this reason, it was never used as a figure.  Likewise, the linear approximation of 
slope was similar to the integrated signal parameter maps but extremely weak in showcasing 
differences.  This is due to the elementary approximation method and could be improved.  The 
rate of decay from a peak value is intriguing as a diagnostic parameter of tissue, although not 
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studied here.  This factor may not be consistent based on spatial location from the source and 
deserves further attention.  In the Krogh-Lattice model, the time for magnetic moments to align 
is assumed to be negligible and signal is measured exactly as it takes place within the tissue.  As 
discussed in section 4.3, this may have implications for the detected contrast agent signal if the 
times of signal acquisition are greater than a second. 
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CHAPTER 6 
CONCLUSIONS 
 
 The Krogh-Lattice is a novel model based on micro-physiological processes at the image 
resolution scale.  The aim of the Krogh-Lattice model is to study microscopic and voxel-based 
dynamic contrast enhancement in magnetic resonance imaging.  A system of microscopic 
exchange between plasma and extravascular-extracellular space is built while numerically 
simulating the local contrast agent flow between and inside image elements.  In the project, 
tissue parameter maps were created, contrast agent was introduced to the tissue via a flow lattice, 
and various data sets were analyzed.  Through simulating the effects of sources, tissue 
heterogeneity, and the contribution of individual tissue parameters to an image, the Krogh-
Lattice model demonstrates the effects of a priori flow maps on image contrast.  Specifically, the 
model attempts to show that flow information is as important as permeability data when 
analyzing tumor contrast enhancement.  By acquiring both flow and permeability data, it may be 
possible to determine tumor type in vivo. 
 Contrast agent distribution simulations can be a tool for modeling the effects of vascular 
and tissue heterogeneity on contrast enhancement.  Although simplifying assumptions of uniform 
flow fields and Krogh cylinder diffusion limitations exist (see Ch. 5), the KL model can provide 
insight and differentiate the contrast agent signal for the same physiological experiment but at 
different MRI resolutions. 
 With the Krogh-Lattice method, it should be possible to predict what imaging data is 
required a priori to more accurately perform radiological-based tissue typing.  The knowledge of 
permeability alone does not allow corroboration of malignant tissue (see Figures 4.4 and 4.5).  
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Rather, given the heterogeneous nature of tumor tissue, permeability and flow maps are critical 
in more accurately determining tumor types.  This implies that, at minimum, dual flow-
permeability maps are necessary for in vivo tumor diagnosis and therapeutic response (see 
Figures 4.10 and 4.11).   
 Source geometry, however, affects contrast enhancement maps independent of flow rate 
and permeability.  This again implies that accurate contrast agent flow maps are critical for in 
vivo tumor typing (see Figures 4.22 and 4.31).   
 In regions of adequate flow, the Krogh-Lattice model is extremely sensitive to even small 
changes of individual tumor tissue parameters, implying that it is a promising tool for estimating 
tumor extraction parameters.  For sub-resolution tumor imaging, the associated data sets indicate 
the presence of oxic cancer at several imaging scales (see Figures 4.33 and 4.34). 
 Due to complex tumor vascular heterogeneity, blood flow sources may not be accurately 
described by existing imaging techniques and contribute to negative diagnostic effects seen in 
the simulations.   An additional source distant from the known flow map, for example, can 
significantly alter several data maps (see Figures 4.8 and 4.9). 
 Further, with a few changes to the existing code, the KL model could be adapted to 
simulate the delivery of therapeutic agents or drugs.  An additional cellular compartment could 
be made available to uptake pharmacological substances in the capillary-tissue array.   
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CHAPTER 7 
FUTURE DIRECTIONS 
 
 Future studies should include non-uniform flow, such as pulsatile, based on other 
experimental data.  Diffusion between EES elements could be enabled as well as diffusion across 
the boundaries of a capillary-tissue assembly.  Setting up a three dimensional tissue space would 
allow a more complex flow situation to be simulated on a voxel basis.  The time of each study 
could also be modified slightly.  First, time averaging of the signal due to the MRI acquisition 
sequence could determine if tumor characteristics are suppressed via this process.  Also, the time 
of numerical experiments could be extended to incorporate the second pass of contrast agent 
through the capillaries for additional tumor characterization.   
 As mentioned in chapter 6, the Krogh-Lattice model could be adapted to add a third 
compartment, such as cellular, for modeling drug delivery.  In this case, the EES would 
exchange the therapeutic agent via another diffusive process with the neighboring cells.  The 
underlying bulk transport would remain the same and enable the KL model to expand into other 
areas of biomedical engineering. 
 In a clinical setting, the Krogh-Lattice model could be adapted to diagnostic use.  For a 
particular image with well mapped flow, a vector flow map could be populated.  Then, with an 
estimated contrast agent concentration in one region of the system, the KL method simulation 
could estimate  for each voxel and identify probable tumor locations. 
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APPENDIX A 
 
MATLAB CODE 
 
 
 The MATLAB© code, with function and subroutine programming, is customizable for 
any desired numerical experiment with different capillary-tissue grid size, number of sources, 
flow fields, tissue parameters, etc.  Prior to the main program, several items are required to be 
initialized to save computational costs and provide input to the main program.  Within the main 
program, several subroutines are called through hundreds of iterative time steps.  Initial 
conditions, boundary conditions, convolution operations (diffusive aspect of contrast agent 
movement), and bulk advection of blood flow within the capillaries are performed.  Filters are 
then applied to simulation data sets to prevent instabilities from forming due to mathematical 
operations with near-zero values.  The remaining subroutines pull various information from the 
capillary-tissue grid for simulation data analysis including contrast agent concentration at the 
current time step in the form of a history array.  Lastly, desired simulation data is plotted and 
stored for later use. 
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Contents 
• Clear old data 
• User Input for CTA 
• Automatic Calculations 
• Setup number of CTEs for CTG 
• Initialize Matrices 
• Setup matrices related to regions to graph 
• Initialize imagetotal matrix and Setup locations of capillaries 
• Setup location of AIF (sources for CA) 
• Modify parameter maps for insertion of cancer 
• START MAIN 
• Outputs 
• End MAIN 
• IC 
• BC 
• CONVOLVE 
• T_ADVECTION 
• ZEROIZE 
• PULL OLD TEST ARRAY DATA FOR EES USE 
• PULL 1-D GRAPH DATA 
• PULL VIDEO FRAMES 
• PLOT 1-D 
function [ output_1 output_2 output_3 output_4 output_5] = dbmodel(thenumberone) 
%dbmodel 
%Krogh Lattice Model 
% 
%(C) Dan Bradley, 2010. 
% 
%Thesis work, NPRE, University of Illinois 
% 
Clear old data 
clc 
clear all 
close all 
tic;                            %Start timer 
User Input for CTA 
bc_width = 2;                   %Setup ghost point width 
I1x = bc_width+1;               %Ghost points 
I1y = bc_width+1; 
nx = 20;      %nx = total number of spatial steps taken in problem along x 
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ny = 20;      %ny = total number of spatial steps taken in problem along y 
dx = .1;      %dx = unit length of x dimension in mm 
dy = .1;      %dy = unit length of y dimension in mm 
I2x = I1x + nx -1;              %Ghost points 
I2y = I1y + ny -1; 
nxdim = nx+2*bc_width; %nxdim = total number points including ghost points 
nydim = ny+2*bc_width; 
dt = .1;                       %dt = time step length 
goaltime = 40;           %intended final time to step to (ex: 30 seconds) 
iterations = goaltime/dt  % total number of time steps taken in problem 
 
%Set healthy tissue parameters 
ve = 0.08                      %ve = EES volume fraction 
Fp = .06/60                    %Fp = blood plasma flow [1/min] 
Tc = 0                         %Tc = mean transit time 
                               % set at zero since time is accounted for 
                               % in advection 
E = 0.42                       %E = extraction fraction 
%fractional calibrated adjustment to courant speed of 1 
speedfactor_x = 0.7; 
speedfactor_y = 0.7; 
method = input(... 
    'Select the method to be used: \n 2 - ... Takacs \n \n Type 2 [2]: '); 
if isempty (method) 
    method = 2; 
end 
 
reruns=1;                       % number of times movie is to play 
fps=30;                         % frames per second 
nframes = iterations;           % number of frames in the movie 
Frames = moviein(nframes);      % initialize the matrix 'Frames' 
AvgFrames = moviein(nframes);   % initialize the matrix 'AvgFrames' 
title('2-D AIF')                % Assign reference for title 
colormap('jet')                 % assign colormaps to default 
map=jet;                        % assign colormap to default 
 
Automatic Calculations 
tdis = linspace(0,goaltime,iterations);     %discrete t to plot over 
Setup number of CTEs for CTG 
numofCTEsx = 6;     %User input for total CTEs in CTG 
numofCTEsy = 6; 
I1xtot = I1x;                   %Ghost points for CTG 
I1ytot = I1y; 
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%Total number of spatial steps taken in problem along x 
nxtot = nxdim*numofCTEsx -2*bc_width; 
nytot = nydim*numofCTEsy-2*bc_width; 
I2xtot = I1xtot + nxtot -1;     %Ghost points for CTG 
I2ytot = I1ytot + nytot -1; 
%Total number of points including ghost points for CTG 
nxdimtot = nxdim*numofCTEsx; 
nydimtot = nydim*numofCTEsy; 
Initialize Matrices 
%Define number of time iterations in Row, Column form 
[R,C] = size(tdis); 
%setup individual arrays for healthy parameters (can change later) 
ve(1:nxdimtot,1:nydimtot) = ve; 
Fp(1:nxdimtot,1:nydimtot) = Fp; 
Tc(1:nxdimtot,1:nydimtot) = Tc; 
E(1:nxdimtot,1:nydimtot) = E; 
speedfactor_x(1:nxdimtot,1:nydimtot) = speedfactor_x; 
speedfactor_y(1:nxdimtot,1:nydimtot) = speedfactor_y; 
%initialize IRF, known as Raath, and AIF. 
%They will be also be found in each convolution 
%statement below 
% AIF = arterial input function (t) 
AIF = vectorize(inline('6.7*(exp(-2/10*t))*(1-exp(-1/10*t))')); 
% Impulse residue function for Adiabatic Approx to Johnson and Wilson 
Raath = @(t) E(1,1)*exp((-E(1,1)*Fp(1,1))*(t-Tc(1,1))/(ve(1,1))); 
Setup matrices related to regions to graph 
%Temporary array to store values for mathematical operations 
C_temp(1,1:iterations) = 0; 
% AIFdis = discrete sampling of arterial input function 
AIFdis = feval(AIF,tdis); 
%Discrete sampling of IRF for Adiabatic Approx to Johnson and Wilson 
Raathdis = feval(Raath,tdis); 
%Setup time stamp, called stamp, to count number of time iterations 
stamp = 1; 
Initialize imagetotal matrix and Setup locations of capillaries 
imgtotal = zeros(numofCTEsx*nxdim,numofCTEsy*nydim);    %CTG 
avgimgtotal = zeros(numofCTEsx*nxdim,numofCTEsy*nydim); %Average of CTAs 
imgtotal_avg = zeros(numofCTEsx*nxdim,numofCTEsy*nydim); %Average of CTG 
peakarray = zeros(numofCTEsx*nxdim,numofCTEsy*nydim);   %Store peak values 
peaktime = zeros(numofCTEsx*nxdim,numofCTEsy*nydim);    %Store peak time 
starttime = zeros(numofCTEsx*nxdim,numofCTEsy*nydim);   %Store nonzero time 
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%Store uptake slope value 
slope = zeros(numofCTEsx*nxdim,numofCTEsy*nydim); 
%Store time information with imgtotal array 
C_all = zeros(nxdimtot,nydimtot,iterations); 
%Store a second copy of time information with imgtotal array 
%for mathematical operations 
imgtotalold = zeros(nxdimtot,nydimtot,iterations+2); 
%Temporary 1-D version of imgtotal to allow advection 
imgtotal1d = zeros(1,nydimtot); 
%Second temporary 1-D version of imgtotal to allow advection 
imgtotal1dnew = zeros(1,nydimtot); 
%Map of first nonzero time to use to find the critical time, Tc 
EESdelay(1:nxdimtot,1:nydimtot) = 0; 
 
%Location of the start of North and South EES regions along x 
for q=1:numofCTEsx 
    capnx(q) = fix(3*nxdim/4)+(q-1)*nxdim; 
    capsx(q) = fix(1*nxdim/4)+(q-1)*nxdim; 
end 
 
%Location of the start of East and West EES regions along y 
for r=1:numofCTEsy 
   capey(r) = fix(3*nydim/4)+(r-1)*nydim; 
   capwy(r) = fix(1*nydim/4)+(r-1)*nydim; 
end 
 
%Location of the end of North and South EES regions along x 
for q=1:numofCTEsx 
    EESnx(q) = capnx(q)+1; 
    EESsx(q) = capsx(q)-1; 
end 
 
%Location of the end of East and West EES regions along y 
for r=1:numofCTEsy 
    EESey(r) = capey(r)+1; 
    EESwy(r) = capwy(r)-1; 
end 
Setup location of AIF (sources for CA) 
source1x = I1x; 
source1y = fix(nydim/4); 
source2x = fix(nxdim/4); 
source2y = I1y; 
source3x = 27; 
source3y = 6; 
source4x = 30; 
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source4y = 3; 
source5x = 78; 
source5y = 75; 
source6x = 75; 
source6y = 78; 
source_4_7x = 75; 
source_4_7y = 126; 
source_4_8x = 78; 
source_4_8y = 123; 
Modify parameter maps for insertion of cancer 
% % %EXP1 
%for the case of 6x6 cancerous tissue 
%for oxic cancer 
for k = fix(1*nydimtot/6):fix(5*nydimtot/6) 
    for L = fix(1*nxdimtot/6):fix(5*nxdimtot/6) 
    E(L,k) = .49; 
    Fp(L,k) = .28/60; 
    ve(L,k) = .45; 
   end 
end 
 
% % % % Hypoxic tissue 
% % for k = fix(2*nydimtot/6):fix(4*nydimtot/6) 
% %     for L = fix(2*nxdimtot/6):fix(4*nxdimtot/6) 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .14/60; 
% %     ve(L,k) = .23; 
% %    end 
% % end 
 
% % % complex exp 08 
% % for L = fix(4*nydimtot/6):fix(5*nydimtot/6) 
% %     for k = fix(4*nxdimtot/6):fix(5*nxdimtot/6) 
% %     %for L = fix(0*nxdimtot/6):fix(1*nxdimtot/6) 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .28/60; 
% %     ve(L,k) = .45; 
% %    end 
% % end 
 
% % % complex exp 12 
% % for L = fix(5*nydimtot/6):fix(6*nydimtot/6) 
% %     for k = 1:fix(1*nxdimtot/6) 
% %     %for L = fix(0*nxdimtot/6):fix(1*nxdimtot/6) 
% %     E(L,k) = .49; 
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% %     Fp(L,k) = .28/60; 
% %     ve(L,k) = .45; 
% %    end 
% % end 
 
% %%%% % complex exp 13 
% % for L = fix(1*nydimtot/6):fix(6*nydimtot/6) 
% %     for k = fix(1*nxdimtot/6):fix(6*nxdimtot/6) 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .28/60; 
% %     ve(L,k) = .45; 
% %    end 
% % end 
% % % % % Hypoxic tissue 
% % for L = fix(2*nydimtot/6):fix(5*nydimtot/6) 
% %     for k = fix(2*nxdimtot/6):fix(5*nxdimtot/6) 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .14/60; 
% %     ve(L,k) = .23; 
% %    end 
% % end 
% % % % % Necrotic tissue 
% % for L = fix(3*nydimtot/6):fix(4*nydimtot/6) 
% %     for k = fix(3*nxdimtot/6):fix(4*nxdimtot/6) 
% %     E(L,k) = 0; 
% %     Fp(L,k) = 0; 
% %     ve(L,k) = .01; 
% %    end 
% % end 
 
% for complex exp 21 
% % for L = 1:fix(6*nydimtot/6) 
% %     for k = fix(1*nxdimtot/6):fix(2*nxdimtot/6) 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .28/60; 
% %     ve(L,k) = .45; 
% %    end 
% % end 
% % for L = 1:fix(6*nydimtot/6) 
% %     for k = fix(3*nxdimtot/6):fix(4*nxdimtot/6) 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .28/60; 
% %     ve(L,k) = .45; 
% %    end 
% % end 
% % for L = 1:fix(6*nydimtot/6) 
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% %     for k = fix(5*nxdimtot/6):fix(6*nxdimtot/6) 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .28/60; 
% %     ve(L,k) = .45; 
% %    end 
% % end 
 
%complex exp 22 
% % for k = 31:41 
% %     for L = 43 
% %     E(L,k) = .49; 
% %     Fp(L,k) = .28/60; 
% %     ve(L,k) = .45; 
% %     end 
% % end 
 
 
% % % complex exp 23 
%averaging one region of cancer (north) with other regions (east, south, 
%west) over a voxel 
% % for L = fix(1*nydimtot/6):fix(2*nydimtot/6) 
% %     for k = fix(1*nxdimtot/6):fix(2*nxdimtot/6) 
% %     %for L = fix(0*nxdimtot/6):fix(1*nxdimtot/6) 
% %     E(L,k) = .4375; 
% %     Fp(L,k) = .115/60; 
% %     ve(L,k) = .1725; 
% %    end 
% % end 
START MAIN 
for n=1:iterations 
 
    %insert source terms for CA 
    imgtotal = ic(imgtotal,AIFdis,n,source1x,source1y); 
    imgtotal = ic(imgtotal,AIFdis,n,source2x,source2y); 
    imgtotal = ic(imgtotal,AIFdis,n,source3x,source3y); 
    imgtotal = ic(imgtotal,AIFdis,n,source4x,source4y); 
%     imgtotal = ic(imgtotal,AIFdis,n,source5x,source5y); 
%     imgtotal = ic(imgtotal,AIFdis,n,source6x,source6y); 
%     imgtotal = ic(imgtotal,AIFdis,n,source_4_7x,source_4_7y); 
%     imgtotal = ic(imgtotal,AIFdis,n,source_4_8x,source_4_8y); 
% 
 
    %timestamp is used to look in the past (time n) for imgtotal array 
    stamp = stamp + 1; 
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    %apply boundary conditions 
    imgtotal = bc(imgtotal,I1x,I1y,I2x,I2y,nxdim,nydim); 
 
    %convolution to calculate EES [CA] and conserve CA 
    for r=1:numofCTEsy 
        for q=1:numofCTEsx 
            [imgtotal imgtotalold EESdelay] = ... 
                convolve(imgtotal,imgtotalold,I1xtot,I1ytot,... 
                I2xtot,I2ytot,nxdimtot,nydimtot,E,Fp,Tc,ve,EESdelay,... 
                capnx(q),capsx(q),capey(r),capwy(r),tdis,n,EESnx(q),... 
                EESsx(q),EESey(r),EESwy(r),capsx(q)+1,capnx(q)-1,... 
                capwy(r)+1,capey(r)-1); 
        end 
    end 
 
   %advection to move capillary [CA] around 
    %insert method check where 2 = Takacs 
    if method == 2 
        for r=1:numofCTEsy 
            for q=1:numofCTEsx 
 
        imgtotal = T_advection(imgtotal,imgtotal1dnew,imgtotal1d,n,... 
            I1xtot,I1ytot,I2xtot,I2ytot,nxdimtot,nydimtot,dt,dx,dy,... 
            speedfactor_x,speedfactor_y,capsx(q),capwy(r),capnx(q),... 
            capey(r)); 
           end 
        end 
    end 
 
    %zeroize small values to prevent undefined operations 
    imgtotal = zeroize(imgtotal,nxdimtot,nydimtot); 
 
    %Pull old imgtotal array data for EES convolution use 
    imgtotalold = pull_old(imgtotal,imgtotalold,nxdim,nydim,stamp); 
 
    %Create an averaging map for grids 
    for r=1:numofCTEsy 
            for q=1:numofCTEsx 
                avgimgtotal(EESsx(q):EESnx(q),EESwy(r):EESey(r)) = ... 
                    mean2(imgtotal(EESsx(q):EESnx(q),EESwy(r):EESey(r))); 
 
            end 
    end 
 
    %Pull data for 1-d graphing 
    %of the form function [C_] = pull_1d(test,C_,n,x_coord,y_coord) 
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    %This step creates the C_all 3-d array to compare integrals of signal 
    %to each other 
    for L=1:nxdimtot 
        for k = 1:nydimtot 
            C_temp = pull_1d(imgtotal,C_temp,n,L,k); 
            C_all(L,k,n) = C_temp(1,n); 
        end 
    end 
    %Pull video frames 
    %Frames = pull_video(imgtotal,Frames,n,nxtot,dt,goaltime, 
    %nxdimtot,nydimtot); 
    %%AvgFrames = pull_video(avgimgtotal,AvgFrames,n,nxtot,dt, 
    %goaltime,nxdimtot,nydimtot); 
 
%end of timeloop n from 1 to iterations 
end 
 
%Plot 1-D 
%This step creates the 2-D map of the integral of the CA for each grid unit 
%over the entire time of the experiment 
for L=1:nxdimtot 
        for k = 1:nydimtot 
 
            C_temp(1,:) = C_all(L,k,:); 
            %Use trapizoidal method 
            imgtotal_avg(L,k) = trapz(1:iterations,C_temp); 
            [max_val,max_time] = max(C_temp); 
            peakarray(L,k) = max_val; 
            peaktime(L,k) = max_time; 
            nonzero_check = any(C_temp); 
            if nonzero_check == 1 
                starttime(L,k) = find(C_temp,1,'first'); 
            else 
            end 
 
            slope(L,k) = peakarray(L,k)/((peaktime(L,k))-(starttime(L,k))); 
        end 
end 
 
slope = zeroize(slope,nxdimtot,nydimtot); 
Outputs 
figure, surf(imgtotal_avg) 
title(['Integrated CA Signal -  Dan Bradley']) 
figure, surf(peakarray) 
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title(['Maximum CA -  Dan Bradley']) 
figure, surf(peaktime) 
title(['Time of Maximum CA -  Dan Bradley']) 
figure, surf(starttime) 
title(['Time of First Nonzero CA -  Dan Bradley']) 
figure, surf(slope) 
title(['CA slope  -  Dan Bradley']) 
 
% Now play the movie: 
%figure, movie(Frames,reruns,fps) 
 
% Now save the movie as an mpeg file for use on the Web: 
%map=colormap 
%mpgwrite(Frames(:,:),jet,'movieaa.mpg') 
%Note: to make an MPG, change folders to the mpgwrite one 
 
%to save as an AVI file 
%movie2avi(Frames(:,:), 'avitest01MAR2011.avi', 'compression', 'Cinepak'); 
 
%movie(Frames) 
%completion is the output arguement 
output_1 = imgtotal_avg; 
output_2 = peakarray; 
output_3 = peaktime; 
output_4 = starttime; 
output_5 = slope; 
% Complete run-time calculation 
toc 
%Now to end the entire dbmodel program 
end 
End MAIN 
IC 
function [test] = ic(test,AIFdis,n,source_y,source_x) 
%IC is the initial conditions where the signal is inserted 
 
%if n <= 1 
%test(source_x,source_y) = 1; 
test(source_x,source_y) = test(source_x,source_y)+10*AIFdis(n); 
%end 
 
end 
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BC 
function [test] = bc(test,I1x,I1y,I2x,I2y,nxdim,nydim) 
%BC is the boundary conditions 
 
for L=1:nxdim 
    test(L,I1y-1) = 0; 
    test(L,I2y+1) = 0; 
end 
 
for k=1:nydim 
    test(I1x-1,k) = 0; 
    test(I2x+1,k) = 0; 
end 
end 
CONVOLVE 
function [test testold EESdelay] = convolve(test,testold,I1x,I1y,... 
    I2x,I2y,nxdim,nydim,E,Fp,Tc,ve,EESdelay,capnx,capsx,capey,capwy,... 
    tdis,n,EESnx,EESsx,EESey,EESwy,x_bound_L,x_bound_R,y_bound_L,y_bound_R) 
%CONVOLVE is the convolution step 
 
%For W element 
for L=x_bound_L:x_bound_R 
 
 
% If the capillary [CA] is greater than the tissue [CA] 
if test(L,capwy) >= test(L,EESwy) 
    Raath = @(t) E(L,EESwy)*exp((-E(L,EESwy)*Fp(L,EESwy))*... 
        (t-Tc(L,EESwy))/(ve(L,EESwy))); 
    Raathdis = feval(Raath,tdis); 
    Raathdis(:) = Fp(L,EESwy); 
    %Use array "temp" to store convolution of capillary and impulse fcn 
    temparray = conv(test(L,capwy),Raathdis); 
    %Represent the tissue as one element above the capillary and pull the time 
    %n'th point in time.   EES [CA] 
    test(L,EESwy) = test(L,EESwy) + temparray(n); 
    %subtract out the EES from the capillary 
    test(L,capwy) = test(L,capwy) - temparray(n); 
    EESdelay(L,(EESwy)) = n; 
else 
    Raath = @(t) E(L,EESwy)*exp((-E(L,EESwy)*Fp(L,EESwy))*... 
        (t-Tc(L,EESwy))/(ve(L,EESwy))); 
    Raathdis = feval(Raath,tdis); 
    temparray = Fp(L,EESwy)*conv(test(L,EESwy),Raathdis); 
    test(L,EESwy) = test(L,EESwy)* (1/(temparray(1)))*... 
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        temparray(n-EESdelay(L,(EESwy))); 
    test(L,capwy) = test(L,capwy) + testold(L,EESwy,n-1) - test(L,EESwy); 
end 
 
 
%end of L loop for W element EES convolution calculation 
end 
 
%For E element 
for L=x_bound_L:x_bound_R 
 
 
 
% If the capillary [CA] is greater than the tissue [CA] 
if test(L,capey) >= test(L,EESey) 
    Raath = @(t) E(L,EESey)*exp((-E(L,EESey)*Fp(L,EESey))*... 
        (t-Tc(L,EESey))/(ve(L,EESey))); 
    Raathdis = feval(Raath,tdis); 
    Raathdis(:) = Fp(L,EESey); 
    %Use array "temp" to store convolution of capillary and impulse fcn 
    temparray = conv(test(L,capey),Raathdis); 
    %Represent the tissue as one element above the capillary and pull the time 
    %n'th point in time.   EES [CA] 
    test(L,EESey) = test(L,EESey) + temparray(n); 
    %subtract out the EES from the capillary 
    test(L,capey) = test(L,capey) - temparray(n); 
    EESdelay(L,(EESey)) = n; 
else 
 
    Raath = @(t) E(L,EESey)*exp((-E(L,EESey)*Fp(L,EESey))*... 
        (t-Tc(L,EESey))/(ve(L,EESey))); 
    Raathdis = feval(Raath,tdis); 
    temparray = Fp(L,EESey)*conv(test(L,EESey),Raathdis); 
    test(L,EESey) = test(L,EESey)*(1/(temparray(1)))*... 
        temparray(n-EESdelay(L,(EESey))); 
    test(L,capey) = test(L,capey) + testold(L,EESey,n-1) - test(L,EESey); 
 
end 
 
 
%end of L loop for E element EES convolution calculation 
end 
 
%For North (N) element 
for k=y_bound_L:y_bound_R 
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% If the capillary [CA] is greater than the tissue [CA] 
if test(capnx,k) >= test(EESnx,k) 
    Raath = @(t) E(EESnx,k)*exp((-E(EESnx,k)*Fp(EESnx,k))*... 
        (t-Tc(EESnx,k))/(ve(EESnx,k))); 
    Raathdis = feval(Raath,tdis); 
    Raathdis(:) = Fp(EESnx,k); 
    %Use array "temp" to store convolution of capillary and impulse fcn 
    temparray = conv(test(capnx,k),Raathdis); 
    %Represent the tissue as one element above the capillary and pull the time 
    %n'th point in time.   EES [CA] 
    test(EESnx,k) = test(EESnx,k) + temparray(n); 
    %subtract out the EES from the capillary 
    test(capnx,k) = test(capnx,k) - temparray(n); 
    EESdelay((EESnx),k) = n; 
else 
 
    Raath = @(t) E(EESnx,k)*exp((-E(EESnx,k)*Fp(EESnx,k))*... 
        (t-Tc(EESnx,k))/(ve(EESnx,k))); 
    Raathdis = feval(Raath,tdis); 
    temparray = Fp(EESnx,k)*conv(test(EESnx,k),Raathdis); 
    test(EESnx,k) = test(EESnx,k)* (1/(temparray(1)))*... 
        temparray(n-EESdelay(EESnx,k)); 
    test(capnx,k) = test(capnx,k) + testold(EESnx,k,n-1) - test(EESnx,k); 
end 
 
 
%end of L loop for N element EES convolution calculation 
end 
 
 
%For South (S) element 
for k=y_bound_L:y_bound_R 
 
 
 
% If the capillary [CA] is greater than the tissue [CA] 
if test(capsx,k) >= test(EESsx,k) 
    Raath = @(t) E(EESsx,k)*exp((-E(EESsx,k)*Fp(EESsx,k))*... 
        (t-Tc(EESsx,k))/(ve(EESsx,k))); 
    Raathdis = feval(Raath,tdis); 
    Raathdis(:) = Fp(EESsx,k); 
    %Use array "temp" to store convolution of capillary and impulse fcn 
    temparray = conv(test(capsx,k),Raathdis); 
    %Represent the tissue as one element above the 
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    %capillary and pull the time 
    %n'th point in time.   EES [CA] 
    test(EESsx,k) = test(EESsx,k) + temparray(n); 
    %subtract out the EES from the capillary 
    test(capsx,k) = test(capsx,k) - temparray(n); 
    EESdelay((EESsx),k) = n; 
 
else 
    Raath = @(t) E(EESsx,k)*exp((-E(EESsx,k)*Fp(EESsx,k))*... 
        (t-Tc(EESsx,k))/(ve(EESsx,k))); 
    Raathdis = feval(Raath,tdis); 
    temparray = Fp(EESsx,k)*conv(test(EESsx,k),Raathdis); 
    test(EESsx,k) = test(EESsx,k)* (1/(temparray(1)))*... 
        temparray(n-EESdelay(EESsx,k)); 
    test(capsx,k) = test(capsx,k) + testold(EESsx,k,n-1) - test(EESsx,k); 
end 
 
 
%end of L loop for S element EES convolution calculation 
end 
 
 
 
end 
T_ADVECTION 
function [test] = T_advection(test,test1dnew,test1d,n,I1x,I1y,... 
    I2x,I2y,nxdim,nydim,dt,dx,dy,speedfactor_x,speedfactor_y,... 
    vessel_x,vessel_y,vessel_2x,vessel_2y) 
%of the form imgtotal = T_advection(imgtotal,imgtotal1dnew, 
%imgtotal1d,n,I1xtot,I1ytot,I2xtot,I2ytot,nxdimtot,nydimtot,dt, 
%dx,dy,speedfactor_x,speedfactor_y,capsx(q),capwy(r),capnx(q),capey(r)); 
%Need to alternate which mode of advection (x or y) occurs first for each 
%time step... such as x,y; y,x; x,y; ect... 
%Use mod(n,2) where this equals 1 if odd and 0 if even 
isodd = mod(n,2); 
 
if isodd == 1 
 
%y advection 
for L=1:nxdim 
for k=1:nydim 
 
test1d(k) = test(L,k); 
 
end 
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for k=I1y:I2y 
 
if L == vessel_x 
 
couranty = speedfactor_y(L,k)*dt/dy; 
 
elseif L == vessel_2x 
 
couranty = speedfactor_y(L,k)*dt/dy; 
 
else 
    couranty = 0*dt/dy; 
end 
 
if couranty >= 0 
 
test1dnew(k) = test1d(k) - (couranty/2)*(test1d(k+1)-test1d(k-1))+... 
    (couranty/2)*(couranty)*(test1d(k+1)-2*test1d(k)+test1d(k-1))-... 
    (1+couranty)*(1/6)*(couranty)*(couranty-1)*(test1d(k+1)-... 
    3*test1d(k)+3*test1d(k-1)-test1d(k-2)); 
 
else 
 
test1dnew(k) = test1d(k) - (couranty/2)*(test1d(k+1)-test1d(k-1))+... 
    (couranty/2)*(couranty)*(test1d(k+1)-2*test1d(k)+test1d(k-1))-... 
    (1+couranty)*(1/6)*(couranty)*(couranty+1)*(test1d(k+1)-... 
    3*test1d(k)+3*test1d(k-1)-test1d(k-2)); 
 
end 
 
end 
for k=1:nydim 
    test(L,k) = test1dnew(k); 
 
    if test(L,k) < 0 
    test(L,k) = abs(test(L,k)); 
    end 
 
 
 
end 
 
 
 
%end of L loop for y advection 
end 
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%x advection 
for k=1:nydim 
for L=1:nxdim 
 
test1d(L) = test(L,k); 
 
end 
for L=I1x:I2x 
 
if k == vessel_y 
    courantx = speedfactor_x(L,k)*dt/dx; 
 
elseif k == vessel_2y 
    courantx = speedfactor_x(L,k)*dt/dx; 
 
else 
    courantx = 0; 
end 
 
if courantx >= 0 
 
test1dnew(L) = test1d(L) - (courantx/2)*(test1d(L+1)-test1d(L-1))+... 
    (courantx/2)*(courantx)*(test1d(L+1)-2*test1d(L)+test1d(L-1))-... 
    (1+courantx)*(1/6)*(courantx)*(courantx-1)*(test1d(L+1)-... 
    3*test1d(L)+3*test1d(L-1)-test1d(L-2)); 
 
else 
 
test1dnew(L) = test1d(L) - (courantx/2)*(test1d(L+1)-test1d(L-1))+... 
    (courantx/2)*(courantx)*(test1d(L+1)-2*test1d(L)+test1d(L-1))-... 
    (1+courantx)*(1/6)*(courantx)*(courantx+1)*(test1d(L+1)-... 
    3*test1d(L)+3*test1d(L-1)-test1d(L-2)); 
 
end 
 
 
end 
for L=1:nxdim 
    test(L,k) = test1dnew(L); 
 
    if test(L,k) < 0 
    test(L,k) = abs(test(L,k)); 
    end 
 
end 
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%end of k loop for x advection 
end 
 
%now to insert the other half of the isodd if check.  That is, to switch 
%the order of operation for advection 
else 
 
    %x advection 
for k=1:nydim 
for L=1:nxdim 
 
test1d(L) = test(L,k); 
 
end 
for L=I1x:I2x 
 
if k == vessel_y 
    courantx = speedfactor_x(L,k)*dt/dx; 
 
elseif k == vessel_2y 
    courantx = speedfactor_x(L,k)*dt/dx; 
 
else 
    courantx = 0; 
end 
 
if courantx >= 0 
 
test1dnew(L) = test1d(L) - (courantx/2)*(test1d(L+1)-test1d(L-1))+... 
    (courantx/2)*(courantx)*(test1d(L+1)-2*test1d(L)+test1d(L-1))-... 
    (1+courantx)*(1/6)*(courantx)*(courantx-1)*(test1d(L+1)-... 
    3*test1d(L)+3*test1d(L-1)-test1d(L-2)); 
 
else 
 
test1dnew(L) = test1d(L) - (courantx/2)*(test1d(L+1)-test1d(L-1))+... 
    (courantx/2)*(courantx)*(test1d(L+1)-2*test1d(L)+test1d(L-1))-... 
    (1+courantx)*(1/6)*(courantx)*(courantx+1)*(test1d(L+1)-... 
    3*test1d(L)+3*test1d(L-1)-test1d(L-2)); 
 
end 
 
 
end 
for L=1:nxdim 
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    test(L,k) = test1dnew(L); 
 
    if test(L,k) < 0 
    test(L,k) = abs(test(L,k)); 
    end 
 
end 
 
%end of k loop for x advection 
end 
 
%Now to insert Y advection as part of the earlier else statement within the 
%isodd check 
 
%y advection 
for L=1:nxdim 
for k=1:nydim 
 
test1d(k) = test(L,k); 
 
end 
for k=I1y:I2y 
 
if L == vessel_x 
 
couranty = speedfactor_y(L,k)*dt/dy; 
 
elseif L == vessel_2x 
 
    couranty = speedfactor_y(L,k)*dt/dy; 
 
else 
    couranty = 0*dt/dy; 
end 
 
if couranty >= 0 
 
test1dnew(k) = test1d(k) - (couranty/2)*(test1d(k+1)-test1d(k-1))+... 
    (couranty/2)*(couranty)*(test1d(k+1)-2*test1d(k)+test1d(k-1))-... 
    (1+couranty)*(1/6)*(couranty)*(couranty-1)*(test1d(k+1)-... 
    3*test1d(k)+3*test1d(k-1)-test1d(k-2)); 
 
else 
 
test1dnew(k) = test1d(k) - (couranty/2)*(test1d(k+1)-test1d(k-1))+... 
    (couranty/2)*(couranty)*(test1d(k+1)-2*test1d(k)+test1d(k-1))-... 
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    (1+couranty)*(1/6)*(couranty)*(couranty+1)*(test1d(k+1)-... 
    3*test1d(k)+3*test1d(k-1)-test1d(k-2)); 
 
end 
 
end 
for k=1:nydim 
    test(L,k) = test1dnew(k); 
 
    if test(L,k) < 0 
    test(L,k) = abs(test(L,k)); 
    end 
 
end 
%end of L loop for y advection 
end 
 
 
%end of isodd if check 
end 
 
 
 
end 
ZEROIZE 
function [test] = zeroize(test,nxdim,nydim) 
 % Zeroize extremely small values of test array to prevent spurious errors 
    for L=1:nxdim 
        for k=1:nydim 
            if test(L,k) < 0.00001 
                test(L,k) = 0; 
            end 
        end 
    end 
 
end 
PULL OLD TEST ARRAY DATA FOR EES USE 
function [testold] = pull_old(test,testold,nxdim,nydim,stamp) 
% for use in EES convolution 
 
for L=1:nxdim 
 for k = 1:nydim 
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testold(L,k,stamp) = test(L,k); 
 end 
end 
 
 
end 
PULL 1-D GRAPH DATA 
function [C_] = pull_1d(test,C_,n,x_coord,y_coord) 
% for use to create graphs 
 
C_(1,n) = test(x_coord,y_coord); 
 
end 
PULL VIDEO FRAMES 
function [Frames] = pull_video(test,Frames,n,nx,dt,goaltime,nxdim,nydim) 
 
 
% SURF VERSION 
% % % Pull Video Frames 
surf(test(1:nxdim,1:nydim)); 
%contourf(test(1:nxdim,1:nydim)); 
%hold on 
%pcolor(test) 
caxis manual 
colorbar 
zlim([0 1]) 
title(['Thesis Graph - For ',int2str(nx),' grid pts, for timestep dt=',... 
    num2str(dt),' at t=',num2str(n*dt),' of ',num2str(goaltime),... 
    'sec - Dan Bradley']) 
   Frames(:,n)=getframe; 
 
 
end 
PLOT 1-D 
function [empty] = plot_1d(data1d,data1d_2,nx,dt) 
 
 
empty = figure, plot(data1d, 'b-') 
hold on 
plot(data1d_2, 'r--') 
plot(data1d+data1d_2,'g-') 
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%plot(AIFdis,'k:') 
%plot(secondmean,'m:') 
title(['Graph - Particular pixels for grid',int2str(nx),... 
    ' & timestep=',num2str(dt),' Dan Bradley']) 
legend('EES element [CA]','Capillary plasma element [CA]',... 
    'Combined EES and plasma [CA]') 
xlabel('time t (sec)') 
ylabel('Concentration(x,t) fraction') 
 
hold off 
 
end 
 
Published with MATLAB® 7.11 
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